Designing regenerative biomaterial therapies for the clinic

Science Translational Medicine

Volumn 4, Issue 160, 2012, Pages

  Thomas Pashuck, E ^a   Stevens, Molly M ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACELLULAR BIOMATERIAL; BIOACTIVE GLASS; BIOCERAMICS; BIOMATERIAL; CELL SURFACE RECEPTOR; GLASS; POLY(ALPHA HYDROXY ACID); POLYMER; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; TISSUE SCAFFOLD; UNCLASSIFIED DRUG;

ARTIFICIAL ORGAN; BIODEGRADABILITY; BIOMATERIAL DESIGN; BONE OVERGROWTH; CELL ADHESION; CELL FUNCTION; CELL INTERACTION; CERVICAL SWELLING; CLASSIFICATION; COST; CROSS LINKING; DEVICE APPROVAL; DEVICE CLASSIFICATION; DRUG DELIVERY SYSTEM; DRUG INDUCED DISEASE; EPIDERMAL HEMATOMA; EXTRACELLULAR MATRIX; HUMAN; HYDROGEL; MEDICAL SOCIETY; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PRODUCT PARAMETERS; REGENERATIVE MEDICINE; REVIEW; SIGNAL TRANSDUCTION; TISSUE ENGINEERING; TRANSLATIONAL RESEARCH;

ANIMALS; BIOCOMPATIBLE MATERIALS; CELL DIFFERENTIATION; HUMANS; MATERIALS TESTING; MODELS, BIOLOGICAL; POLYMERS; REGENERATIVE MEDICINE; STEM CELLS; TISSUE ENGINEERING; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84869469648     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3002717     Document Type: Review

References (102)

1. National Institutes of Health, http://www.nih.gov/about/impact/
2. D. M. Cutler, A. B. Rosen, S. Vijan, The value of medical spending in the United States, 1960-2000. N. Engl. J. Med. 355, 920-927 (2006).
3. E. R. Dorsey, J. de Roulet, J. P. Thompson, J. I. Reminick, A. Thai, Z. White-Stellato, C. A. Beck, B. P. George, H. Moses III, Funding of US biomedical research, 2003-2008. JAMA 303, 137-143 (2010).
4. S. M. Paul, D. S. Mytelka, C. T. Dunwiddie, C. C. Persinger, B. H. Munos, S. R. Lindborg, A. L. Schacht, How to improve R&D productivity: The pharmaceutical industry's grand challenge. Nat. Rev. Drug Discov. 9, 203-214 (2010).
5. B. Munos, Lessons from 60 years of pharmaceutical innovation. Nat. Rev. Drug Discov. 8, 959-968 (2009).
6. C. Mason, E. Manzotti, Regenerative medicine cell therapies: Numbers of units manufactured and patients treated between 1988 and 2010. Regen. Med. 5, 307-313 (2010).
7. A. Jaklenec, A. Stamp, E. Deweerd, A. Sherwin, R. Langer, Progress in the tissue engineering and stem cell industry "are we there yet?" Tissue Eng. Part B Rev. 18, 155-166 (2012).
8. M. J. Lysaght, A. L. Hazlehurst, Tissue engineering: The end of the beginning. Tissue Eng. 10, 309-320 (2004).
9. G. Prestwich, S. Bhatia, C. K. Breuer, S. Dahl, C. Mason, R. McFarland, D. J. McQuillan, J. Sackner-Bernstein, J. Schox, A. Trounson, W. E. Tente, K. LaMarco, M. L. Frisk, What is the greatest regulatory challenge in the translation of biomaterials into the clinic? Sci. Transl. Med. 4, 160cm14 (2012).
10. Guidance for Industry and FDA Staff: Classification of Products as Drugs and Devices & Additional Product Classification Issues; http://www.fda.gov/ downloads/RegulatoryInformation/ Guidances/UCM258957.pdf
11. Medical Technology Innovation Scorecard (PricewaterhouseCoopers LLP, New York, 2011).
12. S. Keyhani, M. Diener-West, N. Powe, Are development times for pharmaceuticals increasing or decreasing? Health Aff. 25, 461-468 (2006).
13. A. Astashkina, B. Mann, D. W. Grainger, A critical evaluation of in vitro cell culture models for high-throughput drug screening and toxicity. Pharmacol. Ther. 134, 82-106 (2012).
14. D. Krewski, D. Acosta Jr., M. Andersen, H. Anderson, J. C. Bailar III, K. Boekelheide, R. Brent, G. Charnley, V. G. Cheung, S. Green Jr., K. T. Kelsey, N. I. Kerkvliet, A. A. Li, L.McCray,O. Meyer, R. D. Patterson, W. Pennie, R. A. Scala, G. M. Solomon, M. Stephens, J. Yager, L. Zeise, Toxicity testing in the 21st century: A vision and a strategy. J. Toxicol. Environ. Health B Crit. Rev. 13, 51-138 (2010).
15. Definition of Primary Mode of Action of a Combination Product (Federal Register).
16. B. Trappmann, J. E. Gautrot, J. T. Connelly, D. G. T. Strange, Y. Li, M. L. Oyen, M. A. Cohen Stuart, H. Boehm, B. Li, V. Vogel, J. P. Spatz, F. M. Watt, W. T. S. Huck, Extracellular-matrix tethering regulates stem-cell fate. Nat. Mater. 11, 642-649 (2012).
17. Institute of Medicine, Medical Devices and the Public's Health: The FDA 510(k) Clearance Process at 35 Years (The National Academies Press, Washington, DC, 2011).
18. J. Makower, A. Meer, L. Denend, FDA Impact on U.S. Medical Technology Innovation (PricewaterhouseCoopers LLP, New York, 2010).
19. K. Hozumi, D. Otagiri, Y. Yamada, A. Sasaki, C. Fujimori, Y. Wakai, T. Uchida, F. Katagiri, Y. Kikkawa, M. Nomizu, Cell surface receptor-specific scaffold requirements for adhesion to laminin-derived peptide-chitosan membranes. Biomaterials 31, 3237-3243 (2010).
20. T. A. Petrie, J. E. Raynor, D. W. Dumbauld, T. T. Lee, S. Jagtap, K. L. Templeman, D. M. Collard, A. J. García, Multivalent integrin-specific ligands enhance tissue healing and biomaterial integration. Sci. Transl. Med. 2, 45ra60 (2010).
21. M. M. Martino, F. Tortelli, M. Mochizuki, S. Traub, D. Ben-David, G. A. Kuhn, R. Müller, E. Livne, S. A. Eming, J. A. Hubbell, Engineering the growth factor microenvironment with fibronectin domains to promote wound and bone tissue healing. Sci. Transl. Med. 3, 100ra89 (2011).
22. R. Censi, P. Di Martino, T. Vermonden, W. E. Hennink, Hydrogels for protein delivery in tissue engineering. J. Control. Release 161, 680-692 (2012).
23. Z. Zhou, P. Yu, H. M. Geller, C. K. Ober, The role of hydrogels with tethered acetylcholine functionality on the adhesion and viability of hippocampal neurons and glial cells. Biomaterials 33, 2473-2481 (2012).
24. A. Haque, X. S. Yue, A. Motazedian, Y. Tagawa, T. Akaike, Characterization and neural differentiation of mouse embryonic and induced pluripotent stem cells on cadherin-based substrata. Biomaterials 33, 5094-5106 (2012).
25. J. J. Moon, S. H. Lee, J. L. West, Synthetic biomimetic hydrogels incorporated with Ephrin-A1 for therapeutic angiogenesis. Biomacromolecules 8, 42-49 (2007).
26. L. Ye, Z. Fan, B. Yu, J. Chang, K. Al Hezaimi, X. Zhou, N. H. Park, C. Y. Wang, Histone demethylases KDM4B and KDM6B promotes osteogenic differentiation of human MSCs. Cell Stem Cell 11, 50-61 (2012).
27. K. T. Love, K. P. Mahon, C. G. Levins, K. A. Whitehead, W. Querbes, J. R. Dorkin, J. Qin, W. Cantley, L. L. Qin, T. Racie, M. Frank-Kamenetsky, K. N. Yip, R. Alvarez, D. W. Y. Sah, A. de Fougerolles, K. Fitzgerald, V. Koteliansky, A. Akinc, R. Langer, D. G. Anderson, Lipid-like materials for low-dose, in vivo gene silencing. Proc. Natl. Acad. Sci. U.S.A. 107, 1864-1869 (2010).
28. A. J. Engler, S. Sen, H. L. Sweeney, D. E. Discher, Matrix elasticity directs stem cell lineage specification. Cell 126, 677-689 (2006).
29. R. McBeath, D. M. Pirone, C. M. Nelson, K. Bhadriraju, C. S. Chen, Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. Dev. Cell 6, 483-495 (2004).
30. S. H. Lim, X. Y. Liu, H. Song, K. J. Yarema, H. Q. Mao, The effect of nanofiber-guided cell alignment on the preferential differentiation of neural stem cells. Biomaterials 31, 9031-9039 (2010).
31. B. G. Keselowsky, D. M. Collard, A. J. García, Integrin binding specificity regulates biomaterial surface chemistry effects on cell differentiation. Proc. Natl. Acad. Sci. U.S.A. 102, 5953-5957 (2005).
32. Guidance for Industry and FDA Staff: Interpretation of the Term "Chemical Action" in the Definition of Device under Section 201(h) of the Federal Food, Drug, and Cosmetic Act; http://www.fda.gov/downloads/ RegulatoryInformation/Guidances/UCM259068.pdf
33. X. Liu, J. M. Holzwarth, P. X. Ma, Functionalized synthetic biodegradable polymer scaffolds for tissue engineering. Macromol. Biosci. 12, 911-919 (2012).
34. L. S. Nair, C. T. Laurencin, Biodegradable polymers as biomaterials. Prog. Polym. Sci. 32, 762-798 (2007).
35. S. Yang, K. F. Leong, Z. Du, C. K. Chua, The design of scaffolds for use in tissue engineering. Part I. Traditional factors. Tissue Eng. 7, 679-689 (2001).
36. G. Wei, P. X. Ma, Nanostructured biomaterials for regeneration. Adv. Funct. Mater. 18, 3566-3582 (2008).
37. K. G. Sreejalekshmi, P. D. Nair, Biomimeticity in tissue engineering scaffolds through synthetic peptide modifications-altering chemistry for enhanced biological response. J. Biomed. Mater. Res. A 96, 477-491 (2011).
38. M. Barczyk, S. Carracedo, D. Gullberg, Integrins. Cell Tissue Res. 339, 269-280 (2010).
39. A. M. Kloxin, A. M. Kasko, C. N. Salinas, K. S. Anseth, Photodegradable hydrogels for dynamic tuning of physical and chemical properties. Science 324, 59-63 (2009).
40. A. Ranga, M. P. Lutolf, High-throughput approaches for the analysis of extrinsic regulators of stem cell fate. Curr. Opin. Cell Biol. 24, 236-244 (2012).
41. L. Almany, D. Seliktar, Biosynthetic hydrogel scaffolds made from fibrinogen and polyethylene glycol for 3D cell cultures. Biomaterials 26, 2467-2477 (2005).
42. A. T. Hillel, S. Unterman, Z. Nahas, B. Reid, J. M. Coburn, J. Axelman, J. J. Chae, Q. Guo, R. Trow, A. Thomas, Z. Hou, S. Lichtsteiner, D. Sutton, C. Matheson, P. Walker, N. David, S. Mori, J. M. Taube, J. H. Elisseeff, Photoactivated composite biomaterial for soft tissue restoration in rodents and in humans. Sci. Transl. Med. 3, 93ra67 (2011).
43. T. Aida, E. W. Meijer, S. I. Stupp, Functional supramolecular polymers. Science 335, 813-817 (2012).
44. M. J. Webber, J. Tongers, C. J. Newcomb, K.-T. Marquardt, J. Bauersachs, D. W. Losordo, S. I. Stupp, Supramolecular nanostructures that mimic VEGF as a strategy for ischemic tissue repair. Proc. Natl. Acad. Sci. U.S.A. 108, 13438-13443 (2011).
45. Y.-D. Lin, C.-Y. Luo, Y.-N. Hu, M.-L. Yeh, Y.-C. Hsueh, M.-Y. Chang, D.-C. Tsai, J.-N. Wang, M.-J. Tang, E. I. H. Wei, M. L. Springer, P. C. H. Hsieh, Instructive nanofiber scaffolds with VEGF create a microenvironment for arteriogenesis and cardiac repair. Sci. Transl. Med. 4, 146ra109 (2012).
46. V. M. Tysseling-Mattiace, V. Sahni, K. L. Niece, D. Birch, C. Czeisler, M. G. Fehlings, S. I. Stupp, J. A. Kessler, Self-assembling nanofibers inhibit glial scar formation and promote axon elongation after spinal cord injury. J. Neurosci. 28, 3814-3823 (2008).
47. J. S. Rudra, T. Sun, K. C. Bird, M. D. Daniels, J. Z. Gasiorowski, A. S. Chong, J. H. Collier, Modulating adaptive immune responses to peptide self-assemblies. ACS Nano 6, 1557-1564 (2012).
48. J. A. Burdick, G. D. Prestwich, Hyaluronic acid hydrogels for biomedical applications. Adv. Mater. 23, H41-H56 (2011).
49. A. D. Baldwin, K. L. Kiick, Polysaccharide-modified synthetic polymeric biomaterials. Biopolymers 94, 128-140 (2010).
50. W. P. Daley, S. B. Peters, M. Larsen, Extracellular matrix dynamics in development and regenerative medicine. J. Cell Sci. 121, 255-264 (2008).
51. K. Lee, E. A. Silva, D. J. Mooney, Growth factor delivery-based tissue engineering: General approaches and a review of recent developments. J. R. Soc. Interface 8, 153-170 (2011).
52. S. Thorsteinsdóttir, M. Deries, A. S. Cachaço, F. Bajanca, The extracellular matrix dimension of skeletal muscle development. Dev. Biol. 354, 191-207 (2011).
53. T. R. Cox, J. T. Erler, Remodeling and homeostasis of the extracellular matrix: Implications for fibrotic diseases and cancer. Dis. Model Mech. 4, 165-178 (2011).
54. J. E. Reing, B. N. Brown, K. A. Daly, J. M. Freund, T. W. Gilbert, S. X. Hsiong, A. Huber, K. E. Kullas, S. Tottey, M. T. Wolf, S. F. Badylak, The effects of processing methods upon mechanical and biologic properties of porcine dermal extracellular matrix scaffolds. Biomaterials 31, 8626-8633 (2010).
55. S. F. Badylak, D. O. Freytes, T. W. Gilbert, Extracellular matrix as a biological scaffold material: Structure and function. Acta Biomater. 5, 1-13 (2009).
56. E. J. Vanderploeg, C. G. Wilson, S. M. Imler, C. H.-Y. Ling, M. E. Levenston, Regional variations in the distribution and colocalization of extracellular matrix proteins in the juvenile bovine meniscus. J. Anat. 221, 174-186 (2012).
57. E. P. Brennan, X.-H. Tang, A. M. Stewart-Akers, L. J. Gudas, S. F. Badylak, Chemoattractant activity of degradation products of fetal and adult skin extracellular matrix for keratinocyte progenitor cells. J. Tissue Eng. Regen. Med. 2, 491-498 (2008).
58. E. M. Valliant, J. R. Jones, Softening bioactive glass for bone regeneration: Sol-gel hybrid materials. Soft Matter 7, 5083-5095 (2011).
59. C. Ohtsuki, M. Kamitakahara, T. Miyazaki, Bioactive ceramic-based materials with designed reactivity for bone tissue regeneration. J. R. Soc. Interface 6 (Suppl. 3), S349-S360 (2009).
60. K. Rezwan, Q. Z. Chen, J. J. Blaker, A. R. Boccaccini, Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials 27, 3413-3431 (2006).
61. I. D. Xynos, A. J. Edgar, L. D. Buttery, L. L. Hench, J. M. Polak, Gene-expression profiling of human osteoblasts following treatment with the ionic products of Bioglass 45S5 dissolution. J. Biomed. Mater. Res. 55, 151-157 (2001).
62. M. M. Azevedo, G. Jell, M. D. O'Donnell, R. V. Law, R. G. Hill, M. M. Stevens, Synthesis and characterization of hypoxia-mimicking bioactive glasses for skeletal regeneration. J. Mater. Chem. 20, 8854-8864 (2010).
63. E. Boanini, M. Gazzano, A. Bigi, Ionic substitutions in calcium phosphates synthesized at low temperature. Acta Biomater. 6, 1882-1894 (2010).
64. M. D. O'Donnell, P. L. Candarlioglu, C. A. Miller, E. Gentleman, M. M. Stevens, Materials characterisation and cytotoxic assessment of strontium-substituted bioactive glasses for bone regeneration. J. Mater. Chem. 20, 8934-8941 (2010).
65. H. Yuan, H. Fernandes, P. Habibovic, J. de Boer, A. M. C. Barradas, A. de Ruiter, W. R. Walsh, C. A. van Blitterswijk, J. D. de Bruijn, Osteoinductive ceramics as a synthetic alternative to autologous bone grafting. Proc. Natl. Acad. Sci. U.S.A. 107, 13614-13619 (2010).
66. S. V. Dorozhkin, Bioceramics of calcium orthophosphates. Biomaterials 31, 1465-1485 (2010).
67. BCC Research, Technical and Advanced Structural Ceramics (AVM011D); http://www. bccresearch.com/pressroom/report/code/AVM011D
68. P. C. Bessa, M. Casal, R. L. Reis, Bone morphogenetic proteins in tissue engineering: The road from laboratory to clinic, part II (BMP delivery). J. Tissue Eng. Regen. Med. 2, 81-96 (2008).
69. E. J. Carragee, E. L. Hurwitz, B. K. Weiner, A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: Emerging safety concerns and lessons learned. Spine J. 11, 471-491 (2011).
70. R. G. Wylie, S. Ahsan, Y. Aizawa, K. L. Maxwell, C. M. Morshead, M. S. Shoichet, Spatially controlled simultaneous patterning of multiple growth factors in three-dimensional hydrogels. Nat. Mater. 10, 799-806 (2011).
71. M. P. Lutolf, F. E. Weber, H. G. Schmoekel, J. C. Schense, T. Kohler, R. Müller, J. A. Hubbell, Repair of bone defects using synthetic mimetics of collagenous extracellular matrices. Nat. Biotechnol. 21, 513-518 (2003).
72. D. S. Bramono, S. Murali, B. Rai, L. Ling, W. T. Poh, Z. X. Lim, G. S. Stein, V. Nurcombe, A. J. van Wijnen, S. M. Cool, Bone marrow-derived heparan sulfate potentiates the osteogenic activity of bone morphogenetic protein-2 (BMP-2). Bone 50, 954-964 (2012).
73. R. Tsou, F. F. Isik, Integrin activation is required for VEGF and FGF receptor protein presence on human microvascular endothelial cells. Mol. Cell. Biochem. 224, 81-89 (2001).
74. M. Kim, S. E. Kim, S. S. Kang, Y. H. Kim, G. Tae, The use of de-differentiated chondrocytes delivered by a heparin-based hydrogel to regenerate cartilage in partial-thickness defects. Biomaterials 32, 7883-7896 (2011).
75. H.-J. Park, F. Yang, S.-W. Cho, Nonviral delivery of genetic medicine for therapeutic angiogenesis. Adv. Drug Deliv. Rev. 64, 40-52 (2012).
76. O. A. Ali, N. Huebsch, L. Cao, G. Dranoff, D. J. Mooney, Infection-mimicking materials to program dendritic cells in situ. Nat. Mater. 8, 151-158 (2009).
77. C. H. Arrowsmith, C. Bountra, P. V. Fish, K. Lee,M. Schapira, Epigenetic protein families: A new frontier for drug discovery. Nat. Rev. Drug Discov. 11, 384-400 (2012).
78. M. A. Swartz, S. Hirosue, J. A. Hubbell, Engineering approaches to immunotherapy. Sci. Transl. Med. 4, 148rv9 (2012).
79. L. Qian, Y. Huang, C. I. Spencer, A. Foley, V. Vedantham, L. Liu, S. J. Conway, J.-D. Fu, D. Srivastava, In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature 485, 593-598 (2012).
80. Federal Register (2001).
81. V. Sahni, J. A. Kessler, Stem cell therapies for spinal cord injury. Nat. Rev. Neurol. 6, 363-372 (2010).
82. S. Wang, X. Qu, R. C. Zhao, Clinical applications of mesenchymal stem cells. J. Hematol. Oncol. 5, 19 (2012).
83. E. S. Place, N. D. Evans, M. M. Stevens, Complexity in biomaterials for tissue engineering. Nat. Mater. 8, 457-470 (2009).
84. J.-P. Karam, C. Muscari, C. N. Montero-Menei, Combining adult stem cells and polymeric devices for tissue engineering in infarcted myocardium. Biomaterials 33, 5683-5695 (2012).
85. C. Dieckmann, R. Renner, L. Milkova, J. C. Simon, Regenerative medicine in dermatology: Biomaterials, tissue engineering, stem cells, gene transfer and beyond. Exp. Dermatol. 19, 697-706 (2010).
86. G. Orlando, K. J. Wood, P. De Coppi, P. M. Baptista, K. W. Binder, K. N. Bitar, C. Breuer, L. Burnett, G. Christ, A. Farney, M. Figliuzzi, J. H. Holmes IV, K. Koch, P. Macchiarini, S.-H. Mirmalek Sani, E. Opara, A. Remuzzi, J. Rogers, J. M. Saul, D. Seliktar, K. Shapira-Schweitzer, T. Smith, D. Solomon, M. Van Dyke, J. J. Yoo, Y. Zhang, A. Atala, R. J. Stratta, S. Soker, Regenerative medicine as applied to general surgery. Ann. Surg. 255, 867-880 (2012).
87. S. F. Badylak, D. J. Weiss, A. Caplan, P. Macchiarini, Engineered whole organs and complex tissues. Lancet 379, 943-952 (2012).
88. A. Atala, F. K. Kasper, A. G. Mikos, Engineering complex tissues. Sci. Transl. Med. 4, 160rv12 (2012).
89. A. Atala, Engineering organs. Curr. Opin. Biotechnol. 20, 575-592 (2009).
90. J. J. Yoo, J. Olson, A. Atala, B. Kim, Regenerative medicine strategies for treating neurogenic bladder. Int. Neurourol. J. 15, 109-119 (2011).
91. M. J. Elliott, P. De Coppi, S. Speggiorin, D. Roebuck, C. R. Butler, E. Samuel, C. Crowley, C. McLaren, A. Fierens, D. Vondrys, L. Cochrane, C. Jephson, S. Janes, N. J. Beaumont, T. Cogan, A. Bader, A. M. Seifalian, J. J. Hsuan, M. W. Lowdell, M. A. Birchall, Stem-cell-based, tissue engineered tracheal replacement in a child: A 2-year follow-up study. Lancet 380, 994-1000 (2012).
92. P. Macchiarini, P. Jungebluth, T. Go, M. A. Asnaghi, L. E. Rees, T. A. Cogan, A. Dodson, J. Martorell, S. Bellini, P. P. Parnigotto, S. C. Dickinson, A. P. Hollander, S. Mantero, M. T. Conconi, M. A. Birchall, Clinical transplantation of a tissue-engineered airway. Lancet 372, 2023-2030 (2008).
93. H. C. Ott, T. S.Matthiesen, S.-K. Goh, L. D. Black, S. M. Kren, T. I. Netoff, D. A. Taylor, Perfusion-decellularized matrix: Using nature's platform to engineer a bioartificial heart. Nat. Med. 14, 213-221 (2008).
94. H. C. Ott, B. Clippinger, C. Conrad, C. Schuetz, I. Pomerantseva, L. Ikonomou, D. Kotton, J. P. Vacanti, Regeneration and orthotopic transplantation of a bioartificial lung. Nat. Med. 16, 927-933 (2010).
95. J. S. Miller, K. R. Stevens, M. T. Yang, B. M. Baker, D.-H. T. Nguyen, D. M. Cohen, E. Toro, A. A. Chen, P. A. Galie, X. Yu, R. Chaturvedi, S. N. Bhatia, C. S. Chen, Rapid casting of patterned vascular networks for perfusable engineered three-dimensional tissues. Nat. Mater. 11, 768-774 (2012).
96. B. Derby, Printing and prototyping of tissues and scaffolds. Science 338, 921-926 (2012).
97. S. Baiguera, P. Jungebluth, A. Burns, C. Mavilia, J. Haag, P. De Coppi, P. Macchiarini, Tissue engineered human tracheas for in vivo implantation. Biomaterials 31, 8931-8938 (2010).
98. S. Jung, K. M. Panchalingam, L. Rosenberg, L. A. Behie, Ex vivo expansion of human mesenchymal stem cells in defined serum-free media. Stem Cells Int. 2012, 123030 (2012).
99. L. De Bartolo, A. Lendlein, D. Hofmann, A. Bader, A. de Grey, E. Curcio, E. Drioli, Bio-hybrid organs and tissues for patient therapy: A future vision for 2030. Chem. Eng. Process. 51, 79-87 (2012).
100. T. Sato, R. G. Vries, H. J. Snippert, M. van de Wetering, N. Barker, D. E. Stange, J. H. van Es, A. Abo, P. Kujala, P. J. Peters, H. Clevers, Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 459, 262-265 (2009).
101. D. Huh, B. D. Matthews, A. Mammoto, M. Montoya-Zavala, H. Y. Hsin, D. E. Ingber, Reconstituting organ-level lung functions on a chip. Science 328, 1662-1668 (2010).
102. E. S. Place, J. H. George, C. K. Williams, M. M. Stevens, Synthetic polymer scaffolds for tissue engineering. Chem. Soc. Rev. 38, 1139-1151 (2009).